HCM
ALNY icon

Howard Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Howard Capital Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
3,776
+2,206
+141% +$665K 0.01% 256
2026
Q1 		$519K Sell
1,570
-2,110
-57% -$718K 0.01% 223
2025
Q4 		$1.46M Buy
3,680
+2,826
+331% +$1.25M 0.02% 191
2025
Q3 		$389K Buy
854
+24
+3% +$9.77K 0.01% 335
2025
Q2 		$271K Buy
+830
New +$230K ﹤0.01% 366
2024
Q4 		– Sell
-756
Closed -$208K – 409
2024
Q3 		$208K Buy
+756
New +$197K ﹤0.01% 382

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Howard Capital Management's ALNY Position: Q2 2026 in Review

Howard Capital Management increased its Alnylam Pharmaceuticals (ALNY) stake by 141% in Q2 2026, buying an estimated $665K and bringing the position to 3,776 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #256.

Howard Capital Management first reported a position in ALNY in Q3 2024 and has held it in 6 quarters since. The position peaked at $1.46M in Q4 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Howard Capital Management held 3,776 shares of Alnylam Pharmaceuticals worth $1.14M as of Q2 2026.
  • Howard Capital Management bought 2,206 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $665K.
  • Alnylam Pharmaceuticals made up 0.01% of Howard Capital Management's portfolio in Q2 2026, its #256 holding.
  • Howard Capital Management first reported a position in Alnylam Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Howard Capital Management's Alnylam Pharmaceuticals position peaked at $1.46M in Q4 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.